3-(3-Chloropropyl)-7,8-dimethoxy-1H-3-benzazepin-2(3H)-one
99%
- Product Code: 51839
CAS:
85175-59-3
| Molecular Weight: | 295.76 g./mol | Molecular Formula: | C₁₅H₁₈ClNO₃ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | room temperature, dry |
Product Description:
This compound is primarily utilized in the field of medicinal chemistry and pharmacology due to its structural properties, which make it a potential candidate for drug development. It is often explored for its activity on central nervous system (CNS) targets, particularly as a modulator of dopamine receptors. Researchers investigate its potential in treating neurological and psychiatric disorders, such as schizophrenia, Parkinson's disease, and other dopamine-related conditions. Additionally, its unique benzazepine core structure allows for further chemical modifications, enabling the development of novel therapeutic agents with improved efficacy and selectivity. The compound is also studied in preclinical research to understand its pharmacokinetics, metabolism, and safety profile, which are critical for advancing it into clinical trials.
Product Specification:
| Test | Specification |
|---|---|
| APPEARANCE | White to Off-white Powder or Crystals |
| PURITY | 98.5-100 |
| Infrared spectrum | Conforms to Structure |
| NMR | Conforms to Structure |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 5.000 | 10-20 days | Ft18,208.24 |
+
-
|
| 25.000 | 10-20 days | Ft75,849.72 |
+
-
|
3-(3-Chloropropyl)-7,8-dimethoxy-1H-3-benzazepin-2(3H)-one
This compound is primarily utilized in the field of medicinal chemistry and pharmacology due to its structural properties, which make it a potential candidate for drug development. It is often explored for its activity on central nervous system (CNS) targets, particularly as a modulator of dopamine receptors. Researchers investigate its potential in treating neurological and psychiatric disorders, such as schizophrenia, Parkinson's disease, and other dopamine-related conditions. Additionally, its unique benzazepine core structure allows for further chemical modifications, enabling the development of novel therapeutic agents with improved efficacy and selectivity. The compound is also studied in preclinical research to understand its pharmacokinetics, metabolism, and safety profile, which are critical for advancing it into clinical trials.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
Ft0.00
Ft0.00
Total :